CDC panel backs full licensing of Pfizer-BioNTech COVID-19 vaccine
The Advisory Committee on Immunization Practices publicly reviewed data for the first time that supported Pfizer's COVID vaccine's full authorization.
CDC panel backs full licensing of Pfizer-BioNTech COVID-19 vaccine
USATODAY.com
0 shares
1 views
You might like
Related news coverage
Nvidia & darpa biohybrid
Rumble
https://www.youtube.com/watch?v=0Hg7XhbXuac . No One is Talking About What Just Happened..
Advertisement
More coverage
What Pfizer's COVID Vaccine Approval Means
Newsy
Watch VideoIt's been 97 days since Pfizer started submitting data for their full approval application.
Part of that..
